Literature DB >> 29690815

Do proton pump inhibitors modulate the efficacy of anti-PD-1/PD-L1 therapy? A retrospective study.

Sarbajit Mukherjee1, Sami Ibrahimi1, Bilal Khalid1, Darwin Roman2, Daniel Zhao3, Raid Aljumaily1.   

Abstract

Entities:  

Year:  2018        PMID： 29690815     DOI： 10.1177/1078155218771152

Source DB:  PubMed          Journal:  J Oncol Pharm Pract        ISSN： 1078-1552            Impact factor:   1.809


× No keyword cloud information.
  13 in total

1.  Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?

Authors:  Nadiya Hussain; Muntaha Naeem; David J Pinato
Journal:  Hum Vaccin Immunother       Date:  2020-06-23       Impact factor: 3.452

2.  Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150.

Authors:  Ashley M Hopkins; Ganessan Kichenadasse; Ross A McKinnon; Ahmad Y Abuhelwa; Jessica M Logan; Sarah Badaoui; Christos S Karapetis; Andrew Rowland; Michael J Sorich
Journal:  Br J Cancer       Date:  2021-10-28       Impact factor: 7.640

3.  Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.

Authors:  Tomi Jun; Umut Ozbek; Sirish Dharmapuri; Camille Hardy-Abeloos; Huili Zhu; Jung-Yi Lin; Nicola Personeni; Tiziana Pressiani; Naoshi Nishida; Pei-Chang Lee; Chieh-Ju Lee; Hannah Hildebrand; Neil Nimkar; Sonal Paul; Petros Fessas; Muntaha Naeem; Dominik Bettinger; Uqba Khan; Anwaar Saeed; Yi-Hsiang Huang; Masatoshi Kudo; Lorenza Rimassa; Thomas U Marron; David J Pinato; Celina Ang
Journal:  Ther Adv Med Oncol       Date:  2021-04-28       Impact factor: 8.168

4.  Biostimulating Gut Microbiome with Bilberry Anthocyanin Combo to Enhance Anti-PD-L1 Efficiency against Murine Colon Cancer.

Authors:  Xuerun Liu; Luoyang Wang; Nan Jing; Guoqiang Jiang; Zheng Liu
Journal:  Microorganisms       Date:  2020-01-25

Review 5.  Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors.

Authors:  Adviti Naik; Julie Decock
Journal:  Front Oncol       Date:  2020-11-26       Impact factor: 6.244

6.  The effect of proton pump inhibitor uses on outcomes for cancer patients treated with immune checkpoint inhibitors: a meta-analysis.

Authors:  Chao Li; Zhengzheng Xia; Anna Li; Jun Meng
Journal:  Ann Transl Med       Date:  2020-12

Review 7.  Proton Pump Inhibitors and Oncologic Treatment Efficacy: A Practical Review of the Literature for Oncologists.

Authors:  Angel A T Uchiyama; Pedro A I A Silva; Moisés S M Lopes; Cheng T Yen; Eliza D Ricardo; Taciana Mutão; Jefferson R Pimenta; Larissa M Machado; Denis S Shimba; Renata D Peixoto
Journal:  Curr Oncol       Date:  2021-02-03       Impact factor: 3.677

8.  Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinoma.

Authors:  Yoshiharu Okuyama; Shingo Hatakeyama; Kazuyuki Numakura; Takuma Narita; Toshikazu Tanaka; Yuki Miura; Daichi Sasaki; Daisuke Noro; Noriko Tokui; Teppei Okamoto; Hayato Yamamoto; Shintaro Narita; Takahiro Yoneyama; Yasuhiro Hashimoto; Tomonori Habuchi; Chikara Ohyama
Journal:  BJUI Compass       Date:  2021-10-08

Review 9.  Proton Pump Inhibitors and Cancer: Current State of Play.

Authors:  Marie Bridoux; Nicolas Simon; Anthony Turpin
Journal:  Front Pharmacol       Date:  2022-03-14       Impact factor: 5.810

10.  Effects of concomitant proton pump inhibitor use on immune checkpoint inhibitor efficacy among patients with advanced cancer.

Authors:  Bao-Dong Qin; Xiao-Dong Jiao; Xin-Cheng Zhou; Bin Shi; Jian Wang; Ke Liu; Ying Wu; Yan Ling; Yuan-Sheng Zang
Journal:  Oncoimmunology       Date:  2021-07-21       Impact factor: 8.110
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.